A detailed history of All Terrain Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, All Terrain Financial Advisors, LLC holds 11,077 shares of ABBV stock, worth $1.9 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
11,077
Previous 11,077 -0.0%
Holding current value
$1.9 Million
Previous $1.72 Million 17.54%
% of portfolio
0.87%
Previous 0.79%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $13,359 - $15,465
-100 Reduced 0.89%
11,077 $1.65 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $38,035 - $45,614
-275 Reduced 2.4%
11,177 $1.81 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $68,983 - $79,120
-514 Reduced 4.3%
11,452 $1.54 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $550 - $699
4 Added 0.03%
11,966 $1.83 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $23,756 - $29,475
-180 Reduced 1.48%
11,962 $1.94 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $644 - $815
6 Added 0.05%
12,142 $1.64 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $58,413 - $66,308
549 Added 4.74%
12,136 $1.31 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $8,942 - $9,962
85 Added 0.74%
11,587 $1.31 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $10,141 - $13,692
-126 Reduced 1.08%
11,502 $1.23 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $188,916 - $221,725
-2,199 Reduced 15.9%
11,628 $1.02 Million
Q2 2020

Jul 28, 2020

SELL
$73.37 - $98.18 $46,076 - $61,657
-628 Reduced 4.34%
13,827 $1.36 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $1.71 Million - $2.59 Million
-26,465 Reduced 64.67%
14,455 $1.1 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $119,230 - $149,183
1,653 Added 4.21%
40,920 $3.62 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $30,041 - $36,118
477 Added 1.23%
39,267 $2.97 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $39,617 - $50,639
-603 Reduced 1.53%
38,790 $2.82 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $42,195 - $49,662
-547 Reduced 1.37%
39,393 $3.18 Million
Q4 2018

Feb 15, 2019

SELL
$77.85 - $96.01 $83,533 - $103,018
-1,073 Reduced 2.62%
39,940 $3.68 Million
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $2.51 Million - $2.79 Million
28,261 Added 221.62%
41,013 $3.88 Million
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $5,476 - $6,480
61 Added 0.48%
12,752 $1.18 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $14,445 - $19,343
157 Added 1.25%
12,691 $1.2 Million
Q4 2017

Feb 15, 2018

BUY
$89.56 - $98.21 $1.12 Million - $1.23 Million
12,534
12,534 $1.21 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track All Terrain Financial Advisors, LLC Portfolio

Follow All Terrain Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of All Terrain Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Terrain Financial Advisors, LLC with notifications on news.